204 related articles for article (PubMed ID: 33324145)
1. Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction.
Maloney DM; Chadderton N; Millington-Ward S; Palfi A; Shortall C; O'Byrne JJ; Cassidy L; Keegan D; Humphries P; Kenna P; Farrar GJ
Front Neurosci; 2020; 14():571479. PubMed ID: 33324145
[TBL] [Abstract][Full Text] [Related]
2. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
[TBL] [Abstract][Full Text] [Related]
3. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
[TBL] [Abstract][Full Text] [Related]
4. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
5. Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct
Pohl KA; Zhang X; Pham AH; Chan JW; Sadun AA; Yang XJ
Front Genet; 2023; 14():1251216. PubMed ID: 37745862
[TBL] [Abstract][Full Text] [Related]
6. OPA1 expression in the normal rat retina and optic nerve.
Ju WK; Misaka T; Kushnareva Y; Nakagomi S; Agarwal N; Kubo Y; Lipton SA; Bossy-Wetzel E
J Comp Neurol; 2005 Jul; 488(1):1-10. PubMed ID: 15912498
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 correction of
Sladen PE; Perdigão PRL; Salsbury G; Novoselova T; van der Spuy J; Chapple JP; Yu-Wai-Man P; Cheetham ME
Mol Ther Nucleic Acids; 2021 Dec; 26():432-443. PubMed ID: 34589289
[TBL] [Abstract][Full Text] [Related]
8. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
[TBL] [Abstract][Full Text] [Related]
9. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.
Sarzi E; Seveno M; Angebault C; Milea D; Rönnbäck C; Quilès M; Adrian M; Grenier J; Caignard A; Lacroux A; Lavergne C; Reynier P; Larsen M; Hamel CP; Delettre C; Lenaers G; Müller A
Hum Mol Genet; 2016 Jun; 25(12):2539-2551. PubMed ID: 27260406
[TBL] [Abstract][Full Text] [Related]
10. Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis.
Del Dotto V; Carelli V
Front Neurol; 2021; 12():681326. PubMed ID: 34177786
[TBL] [Abstract][Full Text] [Related]
11. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation.
Chun BY; Rizzo JF
Curr Opin Ophthalmol; 2016 Nov; 27(6):475-480. PubMed ID: 27585216
[TBL] [Abstract][Full Text] [Related]
12. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
13. Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction.
Roubertie A; Leboucq N; Picot MC; Nogue E; Brunel H; Le Bars E; Manes G; Angebault Prouteau C; Blanchet C; Mondain M; Chevassus H; Amati-Bonneau P; Sarzi E; Pagès M; Villain M; Meunier I; Lenaers G; Hamel CP
J Neurol Sci; 2015 Feb; 349(1-2):154-60. PubMed ID: 25641387
[TBL] [Abstract][Full Text] [Related]
14. Changes in Mitochondrial Morphology and Bioenergetics in Human Lymphoblastoid Cells With Four Novel OPA1 Mutations.
Kao SH; Yen MY; Wang AG; Yeh YL; Lin AL
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2269-78. PubMed ID: 25744979
[TBL] [Abstract][Full Text] [Related]
15. Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission.
Gerber S; Charif M; Chevrollier A; Chaumette T; Angebault C; Kane MS; Paris A; Alban J; Quiles M; Delettre C; Bonneau D; Procaccio V; Amati-Bonneau P; Reynier P; Leruez S; Calmon R; Boddaert N; Funalot B; Rio M; Bouccara D; Meunier I; Sesaki H; Kaplan J; Hamel CP; Rozet JM; Lenaers G
Brain; 2017 Oct; 140(10):2586-2596. PubMed ID: 28969390
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency.
Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD
Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686
[TBL] [Abstract][Full Text] [Related]
17. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer.
Aijaz S; Erskine L; Jeffery G; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1667-73. PubMed ID: 15161824
[TBL] [Abstract][Full Text] [Related]
18. OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina.
Pesch UE; Fries JE; Bette S; Kalbacher H; Wissinger B; Alexander C; Kohler K
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4217-25. PubMed ID: 15505078
[TBL] [Abstract][Full Text] [Related]
19. OPA1: How much do we know to approach therapy?
Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C
Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676
[TBL] [Abstract][Full Text] [Related]
20. OPA1 functions in mitochondria and dysfunctions in optic nerve.
Lenaers G; Reynier P; Elachouri G; Soukkarieh C; Olichon A; Belenguer P; Baricault L; Ducommun B; Hamel C; Delettre C
Int J Biochem Cell Biol; 2009 Oct; 41(10):1866-74. PubMed ID: 19389483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
